MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
20.18
+0.99
+5.16%
After Hours: 20.20 +0.02 +0.10% 19:59 05/13 EDT
OPEN
19.35
PREV CLOSE
19.19
HIGH
21.10
LOW
18.78
VOLUME
751.33K
TURNOVER
--
52 WEEK HIGH
672.00
52 WEEK LOW
6.76
MARKET CAP
147.81M
P/E (TTM)
-0.1143
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharmaceuticals Holding Corp reports results for the quarter ended March 31 - Earnings Summary
Reuters · 1d ago
*Tonix Pharmaceuticals 1Q Rev $2.43M >TNXP
Dow Jones · 1d ago
Tonix Pharmaceuticals Announces Upcoming FDA PDUFA Goal Date for TNX-102 SL and Positive Phase 1 Results for TNX-1500
NASDAQ · 1d ago
Tonix Pharmaceuticals Q1 EPS $(2.84) Beats $(3.37) Estimate, Sales $2.43M Miss $2.55M Estimate
Benzinga · 1d ago
TONIX PHARMACEUTICALS: CURRENT CASH SUFFICIENT TO FUND OPERATIONS INTO Q2 OF 2026
Reuters · 1d ago
*Tonix Pharmaceuticals 1Q Loss/Shr $2.84 >TNXP
Dow Jones · 1d ago
Press Release: Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
Dow Jones · 1d ago
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
Barchart · 1d ago
More
About TNXP
More
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Recently
Symbol
Price
%Change

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.